Researcher receives Eshelman Institute for Innovation grant to pursue COVID-19 therapy
The Eshelman Institute for Innovation (EII) recently awarded Sam Lai, Ph.D., a $50,000 opportunistic grant to pursue COVID-19 research. The award will fund the development of a number of nebulized monoclonal antibody (mAb)-based therapy against COVID-19. This is based on … Continued